Join us for a comprehensive market status check based on our 2026 survey of over 200 benefits brokers. We'll unpack the ...
Nearly half of all Americans who have retirement savings in a 401(k) or similar plan say they probably would not save for ...
Historically, benefit costs have been the most volatile component of compensation, often rising sharply during economic ...
Benefits groups have joined with unions and patient advocacy groups to ask federal regulators to fix the No Surprises Act ...
A new report shows that the PBMs' critics have already won most of the other high-profile fights.
The initial focus is on GLP-1 medications, a category that has seen significant demand but variable insurance coverage.
Although small businesses employ more than 40 million people in the United States, their workers historically have been far ...
With the issuance of Notice 2024-2, the IRS extended the deadline for most plan sponsors to amend their retirement plans to incorporate required and discretionary changes under the SECURE Act, Miners ...
Their top reasons for staying include satisfaction with their current job or pay, economic uncertainty and a belief that a better opportunity doesn't exist.
Product designers are trying to prepare for the possibility that more employers will drop traditional group plans.
The No Surprises Act independent dispute resolution system is expensive, slow and usually favors the health care providers. A team at the U.S. Department of Health and Human Services has published ...
Beginning Jan. 1, 2027, Novo Nordisk will lower the list price of Wegovy, Ozempic, and Rybelsus. The drug company's Feb. 24 announcement seeks to address access barriers, especially for patients whose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results